Pathophysiology and therapeutic modification of thrombin generation in patients with coronary artery disease

Author： Pothula A.   Serebruany V.L.   Gurbel P.   McKenzie M.E.   Atar D.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.402, Iss.1, 2000-08, pp. : 1-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and Pharmacokinetics of Gallopamil in Patients with Coronary Artery Disease

By Ferrara N.   Longobardi G.   Guerra N.   Nicolino A.   Acanfora D.   Furgi G.   Odierna L.   Rosiello R.   Rengo F.  

Pharmacological Research, Vol. 34, Iss. 1, 1996-07 ,pp. : 37-41

Academic Press

Access to resources Recommend Favorite

Therapeutic angiogenesis: protein-based therapy for coronary artery disease

By Khan Tanveer A   Sellke Frank W   Laham Roger J  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 2, 2003-02 ,pp. : 219-226

Informa Healthcare

Access to resources Recommend Favorite

Matrix Metalloproteinases in Coronary Artery Disease:Clinical and Therapeutic Implications and Pathological Significance

By  

Current Medicinal Chemistry, Vol. 12, Iss. 8, 2005-04 ,pp. : 917-925

Bentham Science Publishers

Access to resources Recommend Favorite

The Impact of Diabetes Mellitus on Coronary Artery Disease: New Therapeutic Approaches

By  

Current Pharmaceutical Design, Vol. 15, Iss. 17, 2009-06 ,pp. : 2037-2048

Bentham Science Publishers

Access to resources Recommend Favorite

Coronary Artery Vasculopathy in Pediatric Cardiac Transplant Patients: The Therapeutic Potential of Immunomodulators

By Pietra Biagio A.   Boucek Mark M.  

Pediatric Drugs, Vol. 5, Iss. 8, 2003-01 ,pp. : 513-524

Adis International

Access to resources Recommend Favorite